CDKN2A and uterine cervix carcinoma in situ: They found that higher ‘immunoscores’ were more frequently observed in CIN III patients than in those with CIN I. Corroborating these results, Kremer and collaborators observed that Ki-67 and p16ink4a scores increased with increasing CIN grade in HIV-infected women.